Efficacy as a Vector: the Relative Prevalence and Paucity of Inverse Agonism¶
Kenakin. (2004). Efficacy as a Vector: the Relative Prevalence and Paucity of Inverse Agonism: the Relative Prevalence and Paucity of Inverse Agonism. Molecular Pharmacology.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Domain-specific¶
- Inverse Agonist
- cannabinoid CB1 receptors, several GPCRs relevant to cardiovascular and CNS pharmacology, and certain nuclear receptors also display constitutive activity making inverse agonist effects clinically observable
This sourceThe prevalence of constitutive receptor activity and inverse agonism across GPCRs.
- cannabinoid CB1 receptors, several GPCRs relevant to cardiovascular and CNS pharmacology, and certain nuclear receptors also display constitutive activity making inverse agonist effects clinically observable
Verification¶
Does it exist? Not checked yet. This work's DOI is recorded above but has not been resolved against an external catalogue, so nothing here confirms the work exists.
Does it back the claim? Not recorded. The single citation of this work carries no recorded support check.
Support is checked per citation rather than per work — the same source can be cited soundly in one article and wrongly in another. Per-citation recording began recently, so a citation with no recorded check is a gap in the record rather than evidence it went unchecked.
See how references were verified.
Registry ID ref:61dc8f3fc1bc · see in the full table